Puma Biotechnology Reports Q2 2026 Financial Results

What Happened

• On August 6, 2026, Puma Biotechnology, Inc. announced its financial results for the second quarter ended June 30, 2026 via a press release. The company furnished that press release as Exhibit 99.1 to the Form 8-K and incorporated it by reference.

Key Details

• Filing date: August 6, 2026 (Form 8-K, Item 2.02: Results of Operations and Financial Condition).
• Reporting period: Quarter ended June 30, 2026.
• Press release: Furnished as Exhibit 99.1 to the 8-K.
• Interactive data: Cover Page Interactive Data File (inline XBRL) included with the filing.

Why It Matters

• This 8-K informs investors that Puma has reported its quarterly earnings and related financial information; investors should review the Exhibit 99.1 press release for revenue, earnings, cash position, and any commentary on trends or guidance. The filing itself does not present the financial tables in-line, so the press release and any subsequent SEC filings (e.g., 10-Q) will provide the detailed figures and context needed to assess near-term business performance.